Skip to main content

Table 3 Clinical outcome related to CIBDAI score before / after treatment in CE dogs

From: S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies

Clinical outcome Number of dogs CIBDAI before treatment Median (range) CIBDAI after treatment Median (range)
Food-responsive enteropathy (FRE) 10 4 (2-9) 0 (0-1)
Antibiotic-responsive enteropathy (ARE) 4 5.5 (1-6) 0 (0-0)
Steroid-responsive enteropathy (SRE) 13 4 (0-7) 0 (0-1)
Steroid non-responsive enteropathy (SNRE) 3 7 (4-9) 9 (4-10)